Abstract
Results
The percentages of participants reporting guideline recommended screening, including identification of pregnancy type by gestational week 13 
Introduction
Twin-twin transfusion syndrome (TTTS) complicates 15% of monochorionic-diamniotic (MCDA) identical twin pregnancies [1] . TTTS carries a high risk of morbidity and mortality for fetuses but can be diagnosed with ultrasound and characteristically presents as an abundance of amniotic fluid for one fetus and lack of fluid for the other [2] . When left untreated, TTTS is 80-100% fatal; however, the increased use of interventions such as laser therapy has resulted in significantly improved survival rates for both twins (69.5%) and at least one twin (89.5%) [3] . TTTS treatments such as laser therapy have been shown most effective when performed in earlier stages of disease progression [4] . In 2013, the Society for Maternal Fetal Medicine published clinical recommendations for optimal MCDA management, suggesting: 1) early ultrasound examination at 10-13 weeks of gestation to determine shared placental status (monochorionicity), and 2) biweekly ultrasounds starting at 16 weeks of gestation and continuing through delivery [2] . Biweekly ultrasounds are critical as ultrasound frequency less often than every two weeks is associated with more advanced TTTS stage at diagnosis [5] . Subsequent to these recommendations, the American Colleges of Obstetrics and Gynecologists have also published ultrasound screening guidelines that indicate that late first trimester/early second trimester screening is indicated to assess for chorionicity [6] . However, despite recommendations, little is known about the timeliness of United States patients' ultrasound screenings and their experiences related to MCDA identification and TTTS screening and diagnosis. Supplemental to this inquiry, the authors also sought to understand if women are being warned about the risks of TTTS, or are receiving referrals to Maternal-Fetal Medicine Specialists (MFM Specialists) after monochorionicity identification. Finally, we sought to understand clinical care experiences, particularly as related to screening and diagnosis, of women who had a pregnancy with TTTS.
Lack of data about patients' screening and diagnostic experiences may be partly due to information gaps about patients prior to presenting at fetal treatment centers [7] , and the difficulty in obtaining a large number of medical records for a rare disease such as TTTS. Given the relative rareness of TTTS and the lack of interoperability among electronic health record systems across the United States, it is impracticable to obtain national data about healthcare practices and screening experiences in this manner. As a first step in understanding the care patients receive, this study aimed to evaluate patient-reported TTTS screening experiences in the United States using a mixed methods approach.
Materials and methods
A retrospective, online survey about TTTS pregnancy experiences was targeted towards women, over the age of 18, living in the United States at the time of pregnancy who completed a TTTS pregnancy. Responses were gathered over a 4-month period in 2016. Participants were recruited through social media groups devoted to TTTS, identical twins, MCDA pregnancies and twins, twin loss, and multiples loss, and through national foundations, including the Twin to Twin Transfusion Syndrome Foundation, Fetal Health Foundation, and Mother of Multiples of America/Mother of Twins. Participants were fully informed that the mixed-methods survey was anonymous. The process of informed consent required participants to review a detailed consent document prior to participating in the survey, and included contact information for the Principal Investigator. They were also provided with contact information for crisis services in the event of a mental or behavioral health crisis during or after participation in the survey. This research was approved by the institutional review boards of Kent State University (protocol number 16-169), D'Youville College and Northeast Ohio Medical University (protocol number 17-010).
Sample
Three hundred and ninety-four women participated in the survey. Twenty participants did not meet inclusion criteria, reducing the sample to 374 respondents. To reduce the possibility of recall bias, the sample was further reduced to 312 to include only women who had been diagnosed with a TTTS pregnancy within the past ten years (2006 to 2016). The respondents were predominately white (89.7%), with a minimum of some college education (90.3%), married (82.1%), and at least $60,000 in annual family income (66.0%). The average participant age during the TTTS pregnancy was 30.3 and most had private insurance (70.6%).
Measures
The online survey asked participants to respond to questions related to their TTTS pregnancy in the following domains:
Demographics. Demographic questions included: age, race, marital status, annual family income, insurance status, education, year of TTTS diagnosis.
Screening and diagnostic experiences. A variable was created to indicate if the TTTS diagnosis occurred during or after 2014, capturing the impact of clinical recommendations published in 2013. Questions related to patient-reported diagnostic experiences in the current study included: 1) gestational week MCDA was identified, 2) type of healthcare provider who determined MCDA pregnancy, 3) warnings about TTTS, 4) referrals to MFM Specialists after MCDA identification, 5) frequency of ultrasounds prior to TTTS diagnosis, 6) treatment for other prenatal conditions prior to TTTS diagnosis, and 7) receipt of routine prenatal care with obstetrician prior to TTTS diagnosis. Gestational week of MCDA determination was dichotomized with 1 indicating MCDA determination before or during gestational week 13 and 0 denoting after week 13. Ultrasound frequency was dichotomized with 1 representing biweekly or more frequent ultrasounds and 0 as less frequent. Pregnancy outcome was assessed (no survivors, single survivor, double survivors) and included in this analysis to control for the possibility that outcome could have influenced participant recall. Open ended questions about patient experiences included: "Do you feel as if you received the best possible care you could have by your primary obstetrician? Please describe, in detail, why yes or no", "Do you feel as if you received the best possible care you could have by your perinatologist/maternal fetal medicine (MFM) specialist? Please describe, in detail, why yes or no.", "Did you ever feel the need to advocate for additional care to your primary obstetrician (or other primary care providers)? If you answered yes, please describe how you advocated and why", if participants answered yes to the previous question "Did your primary obstetrician (or other primary care providers) listen to your concerns and act accordingly?" and "Please give any comments you feel are vital regarding your TTTS experience that were not collected within this survey".
Data analysis
The research team separated quantitative data from qualitative data to conduct analyses, producing individual quantitative and qualitative results. The weight of the survey data rests with the quantitative data (designated by QUAN), and therefore is validated with the qualitative results (designated by qual) using combined (QUAN + qual) interpretation of those results. Investigators conducting the initial quantitative analysis did not conduct the qualitative analysis to reduce potential bias; however, investigators came together to discuss and interpret the combined (QUAN + qual) data. This triangulation design, which validates quantitative data with complementary qualitative data, is a common approach for mixed-methods survey analysis and interpretation [8] , particularly when a quantitative survey includes a few open-ended qualitative questions. This method also permits our research team to expand our quantitative results with qualitative information that allows us to interpret future research needs, develop policy, and inform medical education. Due to the limited qualitative data, thematic analysis was conducted to identify themes that emerged in the data.
Quantitative data were analyzed using Stata 14. Bivariate analyses, including chi-square and t-tests, and a multivariate logistic regression predicting ultrasound frequency were conducted. Qualitative data were coded by hand and checked using Atlas.ti (7 th edition).
Results

Quantitative findings
Fig 1 demonstrates diagnosis and screening trends as reported by participants. Over time, increasing percentages of participants reported having monochorionicity established by week 13. Additionally, the percentage of participants reporting receipt of biweekly or more frequent ultrasounds prior to TTTS diagnosis increased over time, particularly after publication of recommendations in 2013.
To further explore how the dissemination of TTTS screening recommendations in 2013 may have impacted patient-reported screening experiences, comparisons were made before and after 2014 (Table 1 ). There were no significant differences in the number of participants receiving routine prenatal care prior to TTTS diagnosis, number of participants receiving advanced prenatal care due to pregnancy complications not related to TTTS, or the distribution of the type of provider who first determined monochorionicity. Participants diagnosed with TTTS in 2014 and later were marginally more likely to have been informed about the risk of TTTS after monochorionicity identification (62.2%) than those diagnosed in prior years (52.4%). Participants diagnosed with TTTS in later years were also more likely to report referral to a MFM Specialist after monochorionicity identification (72.3%) than those diagnosed between years 2006-2013 (60.4%). Similarly, participants with more recent diagnoses were more likely to have monochorionicity established during or before gestational week 13 (75.7%) than those diagnosed with TTTS in earlier years (60.4%). In addition, the number of participants who reported receiving biweekly or more frequent ultrasounds prior to their TTTS diagnosis significantly increased after publication of screening recommendations from 31.7% to 52.7%, respectively. Nearly half (44.6%) of all participants diagnosed with TTTS in 2014 and later indicated they were not receiving biweekly or more frequent ultrasounds prior to their TTTS diagnosis.
Bivariate analyses explored factors related to the receipt of biweekly or more frequent ultrasounds prior to TTTS diagnosis. This analysis was performed using participants diagnosed with TTTS in the years following the publication of the 2013 recommendations. Participant characteristics including annual income, insurance and education levels were associated with receipt of timely ultrasounds. Pregnancy outcome was not related to reported ultrasound frequency indicating that participant recall of ultrasound frequency was likely not biased based on outcome. Three screening and diagnostic factors were related to ultrasound frequency: (1) monochorionicity established during or before gestational week 13 (χ 2 = 9.02, p<0.01); (2) being informed about the risk of TTTS after monochorionicity determination (χ 2 = 10.74, p = 0.01); and (3) referral to a MFM Specialist after monochorionicity identification (χ 2 = 12.00, p < .01). A multivariate logistic regression identified factors predicting if biweekly or more frequent ultrasounds were received prior to TTTS diagnosis ( Table 2 ). The analysis included all variables established through bivariate analyses to be significantly related to frequency of ultrasounds prior to TTTS diagnosis. Participants informed about the risks of TTTS upon monochorionicity identification had increased odds of receiving biweekly or more frequent ultrasounds (OR 2.82, CI 1.21, 6.56) compared to those who were not warned about risks. In addition, the odds of receiving timely ultrasounds were 4.45 (CI 1.66, 11.93) times higher for those referred to a MFM Specialist upon monochorionicity establishment compared to those who were not referred at that time. Lastly, individuals with monochorionicity determined during or prior to gestational week 13 had increased odds of receiving biweekly or more frequent ultrasounds (OR 4.95, CI 1.72,11.96) compared to those who did not.
Qualitative findings
Two hundred and forty-five participants responded to the questions regarding perceptions of care received by primary care obstetrician and perinatologist/MFM specialist. Responses were categorized into those who indicated they: received the best possible care (52.7%, n = 129), did not receive the best possible care (37.14%, n = 91) and received mixed quality of care (10.2%, n = 25). Table 3 provides themes based on positive, negative or mixed responses. Themes that validate the quantitative findings include the importance of early referral to MFM, provision of comprehensive care through multiple ultrasounds and prenatal visits, and communication of information to patients: "I am very lucky that my OB was knowledgeable about TTTS and referred me to a MFM right away. He also did an ultrasound at my first prenatal appointment and was able to determine modi right away. He also communicated well with the MFM and followed their recommendations for continued care." Likewise, patients who did not receive the best possible care noted the lack of these clinical practices: "She did not refer me to a specialist once she knew I was having identical twins. She did not recognize the symptoms I was having as symptoms of TTTS. She knew about TTTS but didn't explain it to us once we knew we were having ID twins. She just said there is a really rare thing that can happen but don't even worry about it."
(Continued) disclosure of risks 8. Offered hope 9. Did not push termination/abortion "Yes I was offered treatment plans, informed of all complications, and MOST IMPORTANTLY they talked to us with respect. They described all medical terms and never shied away from being absolutely honest while still offering hope!" "Yes. We had 2 very good, well-informed doctors that saw us and gave us a lot of information. They were very proactive and gave us a lot of information at every appointment. They informed us about laser ablation at our first appointment at 14 weeks. They did not push selective reduction or termination." "While we dealt with numerous MFM doctors throughout our TTTS experience they were all very professional and caring. They always wanted the best well-being for myself and our babies." ". . .when I described how uncomfortable I was and how I was in pain, I was laughed at and made to think I was being over dramatic (this was my 3rd pregnancy and my first 2 were very pleasant)."
Most participants (70.9%, n = 171) indicated their perinatologists/MFM Specialists provided the best possible care. Themes focused on the specialists' recognition of the urgency for care: "Right away upon meeting mentioned the need to monitor for TTTS. Then when TTTS appeared referred me to a fetal surgeon within days."
The therapeutic relationship between the specialist, obstetrician, and the patient was emphasized in positive care experiences, particularly in terms of team-based communication, respect, and attentiveness. Conversely, participants who reported they did not receive the best possible care (13.9%, n = 34) highlighted the lack of these components of the patient-physician relationship, as well as the lack of urgency of care (see Table 3 ). Further, one patient reported practice policy prevented her from receiving more frequent visits:
"Their policy was one visit every 4 weeks. At my final appointment I was 18 weeks pregnant and there was already an almost 20% size discordance and despite that and my concerns (which were dismissed), I wasn't scheduled for another appointment for almost 5 weeks." Combinations of the above positive and negative themes "She was very direct about my diagnosis and suggested that I see a specialist and she gave me two options. Then I left and had to research those options and make an appointment fast as the TTTS was progressing quickly. I also had to make reservations to fly to the destination where a specialist could do the laser ablation surgery, and I was offered no help in terms of financial assistance or referred to the Twin to Twin Transfusion Syndrome Foundation for help. I think she did her job for which I am grateful but did the minimum."
"Medically yes. He was excellent. However, after he was done with his part I never saw him again. I work in the same hospital and when I see him he never acknowledges me. It would be nice to have a little more emotional support from him after experiencing something so traumatic under his care." One hundred and seventy-three participants reported how they advocated for care from their primary care obstetrician (Table 4) . Emerging themes focused on seeking additional knowledge through self-education, second opinions, or expert advice. Other participants reported having to demand or beg for additional services such as additional ultrasounds or interventions: "I did personal research and begged for interventions but was denied."
One hundred and twenty-nine participants responded to the final open-ended question of the survey, which asked participants to provide additional thoughts or comments (Table 4) . The majority of these comments consisted of recommendations for improved care of TTTS pregnancies. Suggestions focused on increased education and awareness of TTTS by primary obstetricians and patients, increased access to care, improved emotional support, and policy changes surrounding screening: "I think it should be mandatory for all multiple pregnancies to get weekly ultrasounds, and they should immediately be recommended to an MFM."
Discussion
In this study we found that participants diagnosed after the publication of screening recommendations reported higher rates of biweekly or more frequent ultrasounds and monochorionicity identification prior to gestational week 14. Further, participants with more recent pregnancies also reported increased likelihood of referral to MFM Specialists as well as warnings from healthcare providers about the risk of TTTS. These findings suggest that implementation of recommended TTTS screening procedures, as well as awareness of risks related to MCDA pregnancies, may be increasing in the United States. However, in the years following the publication of screening recommendations, only 52.7% of participants reported receiving ultrasounds at, or greater than, the recommended frequency. Our qualitative findings confirm the women's quantitative answers in terms of the importance of frequent ultrasounds, referral to MFM upon MCDA diagnosis and communication of risks. Qualitative results also help provide context to interpret the quantitative findings. For example, the lack of prenatal visits and ultrasounds may be perceived by patients as the result of hospital or practice policy, but may in fact be a result of reimbursement issues or current practice guidelines.
Current recommendations suggest that MCDA status be identified by gestational week 13 followed by biweekly ultrasounds [2] ; however, practice guidelines also suggest that unless otherwise indicated, a patient receiving a single ultrasound examination during pregnancy should receive it around weeks 18-22 [6] . In addition, there are no current clinical guidelines in the US recommending that MCDA pregnancies be referred to MFM specialists, yet our research suggests that referral to MFM plays an important role both in timely receipt of ultrasounds and in patient perceptions of care. Considering the high risk nature of MCDA pregnancies [9, 10] , it may be advisable for healthcare providers to regularly refer patients with MCDA pregnancies to MFM Specialists.
Beyond the scope of the quantitative research, the qualitative findings highlight the importance of the team-based relationship between the patient, obstetrician, and specialist. Receiving continuity of care through a team approach comprised of both primary obstetrician and specialist was reported by participants who indicated they received high quality care. Team-based care teams have been demonstrated to be associated with patient satisfaction and improved outcomes [11, 12] .
In addition, these results emphasize the role of the therapeutic relationship between patient and healthcare provider. Feeling listened to, respected, supported and receiving ample information impacts patient perceptions of the care they received. Educating patients about the risks of TTTS has the potential to enhance patient empowerment related to disease management and to improve outcomes through several pathways. Patients may demonstrate increased adherence to recommendations, self-monitor more diligently, and increase utilization of health services when symptoms indicate an acute crisis and need for care [13] . Indeed, several review studies indicate that effective physician-patient disease communication is associated with improved health outcomes [14, 15] .
While this research is the first to report pre-TTTS screening experiences using a large sample of mothers who experienced TTTS, there are limitations to the present work. This study used social media for recruitment which likely missed underserved populations and possibly skewed our sample towards individuals who had better and/or worse TTTS experiences and outcomes. However, prior research supports the use of social media to recruit for the study of rare disease [16] . In addition, there was a lack of diversity among the participant population, despite research suggesting that there are limited racial differences among social media use [17] . This may indicate limited diversity within the composition of the social media groups. However, survey respondents possessed overwhelmingly favorable characteristics as they relate to the delivery of healthcare in the US: white, average to high income, high levels of education, married, and privately insured. Despite these protective factors that typically guard against poor healthcare quality [18] nearly half of all women diagnosed after the dissemination of TTTS screening recommendations reported lack of timely ultrasounds. This raises speculative concern for the level of care encountered by populations who traditionally experience health disparities, and further investigation is warranted.
Further, as a self-reported, retrospective survey, recall bias may have been a problem [19] . However, maternal recall obtained within four to six years of the prenatal experience has been found to be 89% accurate when compared to patient charts [20] .
As reported by patients in our study, screening for TTTS may be improving in the United States. However, the need remains for all patients to receive adequate and timely TTTS screening. Our research also indicates that other physician practices such as early identification of monochorionicity, warnings about TTTS and referral to MFM specialist upon monochorionicity establishment are related to increased ultrasound frequency, ultimately improving patient care.
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